These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6412489)
1. [Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin]. Ianishevskaia MN; Kuz'mina NS; Kutimova LR; Lents MN; Minakova LV Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):100-3. PubMed ID: 6412489 [TBL] [Abstract][Full Text] [Related]
2. [The determination of specific Pseudomonas aeruginosa antitoxins in commercial preparations of human immunoglobulin]. Vaneeva NP; Ianishevskaia MN; Aleksandrova TN; Ianshina NL Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):59-61. PubMed ID: 7778378 [TBL] [Abstract][Full Text] [Related]
3. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations]. Chekan LV; Min'ovich FL; Kutimova LR; Edvabnaia LS; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):85-9. PubMed ID: 6170196 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Pollack M; Callahan LT; Taylor NS Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470 [TBL] [Abstract][Full Text] [Related]
5. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations]. Kiseleva IA; Kandiurina VG; Timofeeva GV Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):68-71. PubMed ID: 2424197 [TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361 [TBL] [Abstract][Full Text] [Related]
7. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa. Takeshi K; Homma JY Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439 [TBL] [Abstract][Full Text] [Related]
8. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection]. Vasilev ChL; Veleva KV; Tekelieva RKh; Pencheva PI Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793 [TBL] [Abstract][Full Text] [Related]
9. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. Pollack M; Taylor NS J Clin Microbiol; 1977 Jul; 6(1):58-61. PubMed ID: 407250 [TBL] [Abstract][Full Text] [Related]
10. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa]. Nazarchuk LV Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409 [TBL] [Abstract][Full Text] [Related]
11. [Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime]. Zaĭdner IG; Stanislavskiĭ ES; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):52-7. PubMed ID: 6778023 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by Zhang J; Wan C; Yu B; Gao C; Zhao L; Cheng X; Yang F; Gu H; Zou Q; Gu J; Wang X Hum Vaccin Immunother; 2019; 15(12):2993-3002. PubMed ID: 31116632 [TBL] [Abstract][Full Text] [Related]
13. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. Pollack M J Infect Dis; 1983 Jun; 147(6):1090-8. PubMed ID: 6406615 [TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization. Martinez D; Callahan LT Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia. Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163 [TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577 [TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa exotoxin A. Pollack M N Engl J Med; 1980 Jun; 302(24):1360-2. PubMed ID: 6769039 [No Abstract] [Full Text] [Related]
20. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine]. Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]